← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksIDAIPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

IDAI logoT Stamp Inc. (IDAI) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential

Current Price
$2.50
Market reference
Price Target
—
— Upside
Target Range
— — —
Analyst Rating
—
0 analysts
Forward P/E—
Trailing P/E-0.2x
Forward PEG—
Implied Growth—
Median Target—
Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$2.50
Consensus—
High—
Low—
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—

Analyst Ratings

No analyst coverage available for IDAI

Coverage appears once Wall Street estimates are published.

IDAI Price Target Analysis

Updated May 6, 2026

As of May 6, 2026, T Stamp Inc. (IDAI) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $3M.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, IDAI trades at a trailing P/E of -0.2x.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Technology stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+51.0%
Avg Forward P/E28.8x
Peers with Coverage7 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
ACXP logoACXPAcurx Pharmaceuticals, Inc.$5M$2.09—————
AIOT logoAIOTPowerFleet, Inc.$451M$3.31$8.00+141.7%Buy—5
XTLB logoXTLBXTL Biopharmaceuticals Ltd.$357581$3.25—————
IDCC logoIDCCInterDigital, Inc.$7.2B$278.00$425.00+52.9%Buy38.7x16
CLPS logoCLPSCLPS Incorporation$26M$0.93—————
PRCT logoPRCTPROCEPT BioRobotics Corporation$1.4B$24.80$44.50+79.4%Buy—15
QLYS logoQLYSQualys, Inc.$3.2B$90.84$134.30+47.8%Hold12.3x48
MSFT logoMSFTMicrosoft Corporation$3.1T$413.87$551.75+33.3%Buy24.9x81
GOOGL logoGOOGLAlphabet Inc.$4.8T$397.82$406.28+2.1%Buy29.6x82
AMAT logoAMATApplied Materials, Inc.$339.9B$428.62$426.39-0.5%Buy38.7x53

Upside Potential Comparison

AIOT logoAIOT
+141.7%
PRCT logoPRCT
+79.4%
IDCC logoIDCC
+52.9%
QLYS logoQLYS
+47.8%
MSFT logoMSFT
+33.3%
GOOGL logoGOOGL
+2.1%
AMAT logoAMAT
-0.5%

See IDAI's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is IDAI Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare IDAI vs NVDA

Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.

Start Comparison

IDAI — Frequently Asked Questions

Quick answers to the most common questions about buying IDAI stock.

What is the IDAI stock price target for 2026?

The consensus price target for IDAI is $N/A, close to the current price of $2.5 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.

Is IDAI a buy, sell, or hold?

IDAI has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is IDAI stock overvalued or undervalued?

IDAI's current price is $2.5 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.

How high can IDAI stock go?

The most bullish Wall Street analyst has a price target of $N/A for IDAI, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover IDAI stock?

IDAI is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the IDAI stock forecast?

The 12-month IDAI stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A".

Should I buy IDAI stock?

IDAI appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do IDAI price targets vary so much?

IDAI analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.